1. Analysis of nitrogenous organic compounds from mainstream cigarette smoke using low‐temperature solvent extraction followed by comprehensive two‐dimensional gas chromatography with high‐resolution time‐of‐flight mass spectrometry. Issue 15 (16th June 2015) Authors: Xiang, Zhangmin; Cai, Kai; Zhou, Shuping; Geng, Zhaoliang; Pan, Wenjie Journal: Journal of separation science Issue: Volume 38:Issue 15(2015:Aug.) Page Start: 2655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ASIC1a stimulates the resistance of human hepatocellular carcinoma by promoting EMT via the AKT/GSK3β/Snail pathway driven by TGFβ/Smad signals. Issue 10 (14th April 2022) Authors: Zhang, Yinci; Cao, Niandie; Gao, Jiafeng; Liang, Jiaojiao; Liang, Yong; Xie, Yinghai; Zhou, Shuping; Tang, Xiaolong Journal: Journal of cellular and molecular medicine Issue: Volume 26:Issue 10(2022) Page Start: 2777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy. (20th April 2021) Authors: Cao, Weiya; Liu, Xueke; Zhang, Yinci; Li, Amin; Xie, Yinghai; Zhou, Shuping; Song, Li; Xu, Ruyue; Ma, Yongfang; Cai, Shiyu; Tang, Xiaolong Other Names: Chutipongtanate Somchai Academic Editor. Journal: BioMed research international Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1. (24th August 2022) Authors: Lu, Yeting; Zhou, Shuping; Cheng, Gong; Ruan, Yi; Tian, Yuan; Lv, Kaiji; Han, Shuo; Zhou, Xinhua Other Names: Ding Xiangya Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evidence for ABL Amplification in Multiple Myeloma and Therapeutic Implications. (15th March 2022) Authors: Huang, He; Zhou, Shuping; Lin, Hongdou; Guo, Wenjian; Lin, Ying; Yao, Ronxin; He, Licai; Yu, Kang; Li, Qian Other Names: Raghavamenon Achuthan Chathrattil Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China. Issue 39 (September 2019) Authors: Yao, Rongxin; Hu, Xudong; Zhou, Shuping; Zhang, Qianying; Huang, He; Sun, Ni; Guo, Wenjian; Yu, Kang; Lin, Ying Other Names: Parekh. Parag section editor. Journal: Medicine Issue: Volume 98:Issue 39(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Optical coherence tomography angiography of flat irregular pigment epithelial detachments in central serous chorioretinopathy. Issue 2 (7th April 2020) Authors: Liu, Tingting; Lin, Wei; Zhou, Shuping; Meng, Xiangjuan Journal: British journal of ophthalmology Issue: Volume 105:Issue 2(2021) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Resistance of hepatocellular carcinoma to sorafenib can be overcome with co-delivery of PI3K/mTOR inhibitor BEZ235 and sorafenib in nanoparticles. (2nd April 2020) Authors: Wu, Binquan; Li, Amin; Zhang, Yinci; Liu, Xueke; Zhou, Shuping; Gan, Huaiyong; Cai, Shiyu; Liang, Yong; Tang, Xiaolong Journal: Expert opinion on drug delivery Issue: Volume 17:Number 4(2020) Page Start: 573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. RETRACTED ARTICLE: Trastuzumab-modified DM1-loaded nanoparticles for HER2+ breast cancer treatment: an in vitro and in vivo study. (17th November 2018) Authors: Rong, Ling; Zhou, Shuping; Liu, Xinkuang; Li, Amin; Jing, Tao; Liu, Xueke; Zhang, Yinci; Cai, Shiyu; Tang, Xiaolong Journal: Artificial cells, nanomedicine, and biotechnology Issue: Volume 46:Number 8(2018) Page Start: 1708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Surveillance of carbapenem-resistant Klebsiella pneumoniae in a paediatric hospital in China revealed the dynamics of carbapenemase and the prevalence of ST2735 K. pneumoniae. Issue 1 (21st January 2022) Authors: Zhou, Yan; Zhao, Zeqing; Zeng, Lulu; Peng, Jun; Zhou, Shuping; Min, Liang; Ke, Jiangwei; Liu, Jinhui Journal: Journal of medical microbiology Issue: Volume 71:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗